![Philippe Romagnoli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Philippe Romagnoli first degree
Entity | Entity type | Industry | |
---|---|---|---|
OMRIX Biopharmaceuticals, Inc.
![]() OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ.
19
| Subsidiary | Pharmaceuticals: Major | 19 |
Banque Paribas Belgique SA
2
| Extinct | Regional Banks | 2 |
Artesia Bank
1
| Extinct | Major Banks | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Philippe Romagnoli via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
HighCape Partners Management LLC
![]() HighCape Partners Management LLC Investment ManagersFinance HighCape Partners Management LLC (HighCape Partners) is a private equity firm founded in 2013 by Kevin Rakin and Matt Zuga. The firm headquartered in Westport, Connecticut.. | Investment Managers | Founder Consultant / Advisor | |
Tel-Aviv University
![]() Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Masters Business Admin Masters Business Admin | |
NYXOAH SA | Medical Specialties | Director/Board Member Founder | |
University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree | |
NEURODERM LTD | Biotechnology | Director/Board Member Chairman | |
TransPharma Medical Ltd.
![]() TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Recoly NV
![]() Recoly NV Miscellaneous Commercial ServicesCommercial Services Recoly NV operates as a biotech company focusing on the discovery, development and commercialization of drug enhancing technologies that are used to create bio-better drugs. Its pipeline includes multiple products; all based on their proprietary technologies, in different development stages from marketing authorization filing through pivotal to pre-clinical studies. The company was founded by Robert Taub in 1992 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | President Founder | |
HighCape Capital Acquisition Corp. II
![]() HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
ALLERGAN, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
MONSANTO | Wholesale Distributors | Corporate Officer/Principal | |
Truleaf Medical Ltd. | Director/Board Member | ||
University of Antwerp | College/University | Undergraduate Degree | |
INSEAD | College/University | Masters Business Admin | |
Allevetix Medical Ltd. | Director/Board Member | ||
DELTA GALIL INDUSTRIES LTD. | Apparel/Footwear | Director of Finance/CFO | |
Octapharma AG
![]() Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | Pharmaceuticals: Major | Founder | |
Revlon Healthcare | Corporate Officer/Principal | ||
Allium Ltd. | Director/Board Member | ||
BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal | |
OVVI Diagnostics France SE
![]() OVVI Diagnostics France SE Miscellaneous Commercial ServicesCommercial Services OVVI Diagnostics France SE develops diagnostic tests for cardiovascular diseases. The firm’s technology include MIAtek technology, MIAplex technology and instruments for emergency diagnostic test for cardio-vascular diseases. The company was founded by Petr Nikitin, Jean-Patrick Voisin and Daniel Bernard in 2003 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
AYA GOLD & SILVER INC. | Precious Metals | Chairman | |
LifeBond Ltd.
![]() LifeBond Ltd. Medical SpecialtiesHealth Technology LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel. | Medical Specialties | Director/Board Member | |
Man & Science NV
![]() Man & Science NV Pharmaceuticals: MajorHealth Technology Man & Science NV is a Belgian medical device company that develops a novel, minimally invasive, battery-free neurostimulation system to reduce the pain and frequency of severe headache attacks. The company is based in Mont-Saint-Guibert, Belgium, and has subsidiaries in Norway. The company's therapies allow headache patients to return to a normal, pain-free life. The company's team consists of experienced scientists, engineers, clinical research specialists, business experts, and successful start-up founders and entrepreneurs. The company was founded in 2011 by Robert Taub, and Fabian Suarez Gonzalez has been the CEO of the company since 2022. | Pharmaceuticals: Major | Founder | |
Robelga SRL
![]() Robelga SRL Miscellaneous Commercial ServicesCommercial Services Robelga SRL provides business and management advisory services. The private company is based in Uccle, Belgium. The Belgian company was founded in 2008. The CEO is Robert Taub. | Miscellaneous Commercial Services | Chief Executive Officer | |
Herpain Urbis Retail Holding SA
![]() Herpain Urbis Retail Holding SA Financial ConglomeratesFinance Herpain Urbis Retail Holding SA is an investment holding Belgian company. The private company is based in Uccle, Belgium. The company was founded in 2015. Yvan Neirinckx has been the CEO of the company since 2015. | Financial Conglomerates | Director/Board Member | |
Novozymatic SA | Director/Board Member | ||
Nivelles Service Center SA | Director/Board Member | ||
I.B.I Israel Biomedical Innovations Ltd.
![]() I.B.I Israel Biomedical Innovations Ltd. Medical SpecialtiesHealth Technology I.B.I Israel Biomedical Innovations Ltd. provides surgical and medical solutions specifically for gynecology, urology and gastroenterology. The company was founded in 2004 and is headquartered in Haogen, Israel. | Medical Specialties | Chief Executive Officer | |
UPMC Enterprises
![]() UPMC Enterprises Investment ManagersFinance UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania. | Investment Managers | Consultant / Advisor | |
ALLMED SOLUTIONS LTD | Pharmaceuticals: Other | Director/Board Member | |
Multiple Sclerosis Society
![]() Multiple Sclerosis Society Miscellaneous Commercial ServicesCommercial Services The Multiple Sclerosis Society is an organization that aims to find treatments for everyone affected by multiple sclerosis. The non-profit company is based in London, UK. The British company offers award-winning publications, factsheets, and booklets through their online shop. The society conducts surveys to shape the future direction of MS research, with the latest survey held in 2022 with over 6,500 participants. The company's current focus is on the STARMS trial, which compares HSCT with other highly effective treatments for relapsing MS. The treatment involves using chemotherapy to remove harmful immune cells and regrow the immune system using the patient's own stem cells. Nick Moberly has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Southcoast Hospitals Group, Inc.
![]() Southcoast Hospitals Group, Inc. Hospital/Nursing ManagementHealth Services Southcoast Hospitals Group, Inc. provides healthcare services. The company was founded in 1996 and is headquartered in Fall River, MA. | Hospital/Nursing Management | Director/Board Member | |
REVO BIOLOGICS INC | Biotechnology | Director/Board Member | |
Symmes Life Care, Inc.
![]() Symmes Life Care, Inc. Medical/Nursing ServicesHealth Services Symmes Life Care, Inc. provides residential care services. It offers rehabilitation services. The company was founded in 1994 and is headquartered in Lexington, MA. | Medical/Nursing Services | Director/Board Member | |
Health Helm, Inc. | Founder | ||
CRF, Inc.
![]() CRF, Inc. Packaged SoftwareTechnology Services CRF, Inc. provides electronic Clinical Outcome Assessment (eCOA) solutions. eCOA encompasses PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes), and ClinROs (Clinician or Rater Reported Outcomes). The firm's platforms include TrialStudio, TrialMax, and TrialManager. The company was founded by Timo Ahopelto, Jarkko Joki-Tokola and Jaakko Ollila in 2000 and is headquartered in Plymouth Meeting, PA. | Packaged Software | Chief Executive Officer | |
American Kidney Fund, Inc.
![]() American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Medical/Nursing Services | Director/Board Member | |
PLSG Capital Investment Programs
![]() PLSG Capital Investment Programs Investment ManagersFinance Founded in 2002, PLSG Capital Investment Programs is a venture capital/private equity firm located in Pittsburgh, Pennsylvania. | Investment Managers | Corporate Officer/Principal | |
COGNITION THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
National Heart, Lung & Blood Institute | General Government | Corporate Officer/Principal | |
National Institute of Allergy & Infectious Diseases | General Government | Corporate Officer/Principal | |
Pittsburgh Life Sciences Green House
![]() Pittsburgh Life Sciences Green House Investment ManagersFinance Pittsburgh Life Sciences Green House (PLSG) is a venture capital firm founded in 2002. The firm is headquartered in Pittsburgh, Pennsylvania. | Investment Managers | Private Equity Investor |
Statistics
International
United States | 25 |
Israel | 13 |
Belgium | 10 |
France | 3 |
Switzerland | 2 |
Sectoral
Health Technology | 16 |
Finance | 8 |
Consumer Services | 7 |
Commercial Services | 6 |
Health Services | 4 |
Operational
Director/Board Member | 113 |
Corporate Officer/Principal | 49 |
Chief Executive Officer | 29 |
Chairman | 22 |
Independent Dir/Board Member | 21 |
Most connected contacts
Insiders | |
---|---|
Kevin Rakin | 35 |
Robert Taub | 27 |
Steven St. Peter | 26 |
Hank Safferstein | 19 |
Larry Ellberger | 16 |
Fredric D. Price | 16 |
Ana I. Stancic | 14 |
Pamela W. McNamara | 13 |
Jeffrey Edwards | 13 |
Peter Vermeiren | 12 |
Asaf Alperovitz | 11 |
Nanci I. Prado | 11 |
Joseph Akers | 11 |
Michael Burshtine | 8 |
V. Marc Droppert | 8 |
- Stock Market
- Insiders
- Philippe Romagnoli
- Company connections